MedApp Statistics

Total Valuation

MedApp has a market cap or net worth of PLN 37.39 million. The enterprise value is 41.81 million.

Market Cap	37.39M
Enterprise Value	41.81M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

MedApp has 250.13 million shares outstanding.

Current Share Class	250.13M
Shares Outstanding	250.13M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	120.53M

Valuation Ratios

The trailing PE ratio is 146.14.

PE Ratio	146.14
Forward PE	n/a
PS Ratio	4.92
PB Ratio	1.32
P/TBV Ratio	n/a
P/FCF Ratio	182.41
P/OCF Ratio	98.41
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.37, with an EV/FCF ratio of 203.97.

EV / Earnings	163.34
EV / Sales	5.50
EV / EBITDA	9.37
EV / EBIT	90.31
EV / FCF	203.97

Financial Position

The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.07.

Current Ratio	1.05
Quick Ratio	0.36
Debt / Equity	0.07
Debt / EBITDA	0.46
Debt / FCF	9.96
Interest Coverage	3.86

Financial Efficiency

Return on equity (ROE) is 1.17% and return on invested capital (ROIC) is 0.95%.

Return on Equity (ROE)	1.17%
Return on Assets (ROA)	0.75%
Return on Invested Capital (ROIC)	0.95%
Return on Capital Employed (ROCE)	1.57%
Revenue Per Employee	542,786
Profits Per Employee	18,286
Employee Count	32
Asset Turnover	0.20
Inventory Turnover	0.69

Taxes

In the past 12 months, MedApp has paid 23,000 in taxes.

Income Tax	23,000
Effective Tax Rate	6.59%

Stock Price Statistics

The stock price has decreased by -53.43% in the last 52 weeks. The beta is 1.04, so MedApp's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	-53.43%
50-Day Moving Average	0.16
200-Day Moving Average	0.18
Relative Strength Index (RSI)	53.97
Average Volume (20 Days)	35,250

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedApp had revenue of PLN 7.60 million and earned 256,000 in profits. Earnings per share was 0.00.

Revenue	7.60M
Gross Profit	2.65M
Operating Income	463,000
Pretax Income	349,000
Net Income	256,000
EBITDA	4.46M
EBIT	463,000
Earnings Per Share (EPS)	0.00

Full Income Statement

Balance Sheet

The company has 409,000 in cash and 2.04 million in debt, giving a net cash position of -1.63 million or -0.01 per share.

Cash & Cash Equivalents	409,000
Total Debt	2.04M
Net Cash	-1.63M
Net Cash Per Share	-0.01
Equity (Book Value)	28.38M
Book Value Per Share	0.10
Working Capital	577,000

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 380,000 and capital expenditures -175,000, giving a free cash flow of 205,000.

Operating Cash Flow	380,000
Capital Expenditures	-175,000
Free Cash Flow	205,000
FCF Per Share	0.00

Full Cash Flow Statement

Margins

Gross margin is 34.81%, with operating and profit margins of 6.09% and 3.37%.

Gross Margin	34.81%
Operating Margin	6.09%
Pretax Margin	4.59%
Profit Margin	3.37%
EBITDA Margin	58.73%
EBIT Margin	6.09%
FCF Margin	2.70%

Dividends & Yields

MedApp does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	0.68%
FCF Yield	0.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MedApp has an Altman Z-Score of 2.93 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.93
Piotroski F-Score	5